The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 18, 2014

Filed:

Oct. 21, 2013
Applicant:

Glenmark Pharmaceuticals, S.a., La Chaux-de-Fonds, CH;

Inventors:

Sukeerthi Kumar, Navi Mumbai, IN;

Abraham Thomas, Navi Mumbai, IN;

Sachin Sundarlal Chaudhari, Navi Mumbai, IN;

Bipin Parsottam Kansagra, Ahmedabad, IN;

Venkata Ramana Yemireddy, Navi Mumbai, IN;

Neelima Khairatkar-Joshi, Thane, IN;

Indranil Mukhopadhyay, Navi Mumbai, IN;

Girish Gudi, Mumbai, IN;

Assignee:

Glenmark Pharmaceuticals, S.A., La Chaux-de-Fonds, CH;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 491/00 (2006.01); C07D 211/60 (2006.01); C07D 277/00 (2006.01); A61K 31/519 (2006.01); A61K 31/445 (2006.01); A61K 31/425 (2006.01); C07D 513/04 (2006.01); C07D 491/048 (2006.01); C07D 495/04 (2006.01); C07D 491/04 (2006.01); C07F 9/6561 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
C07F 9/6561 (2013.01); C07D 513/04 (2013.01); C07D 491/048 (2013.01); C07D 495/04 (2013.01); C07D 491/04 (2013.01); C07F 9/65616 (2013.01); C07D 487/04 (2013.01);
Abstract

The present invention is related to 2-amino-4-arylthiazole derivatives as TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.


Find Patent Forward Citations

Loading…